Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM96KXE)

Drug Name
Peptide analog 41 Drug Info
Synonyms PMID29865878-Compound-6
Cross-matching ID
TTD Drug ID
DM96KXE

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Proteasome beta-9 (PS beta-9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Peptide analog 21 DMJDFS1 N. A. N. A. Patented [1]
Peptide analog 23 DMDU21R N. A. N. A. Patented [1]
PMID29865878-Compound-53 DM6JV1W N. A. N. A. Patented [1]
PMID29865878-Compound-55 DMY52ZB N. A. N. A. Patented [1]
PMID29865878-Compound-46 DMP3MXK N. A. N. A. Patented [1]
PMID29865878-Compound-48 DMVQTR2 N. A. N. A. Patented [1]
PMID29865878-Compound-51 DM0LXT2 N. A. N. A. Patented [1]
PMID29865878-Compound-49 DMK0GTV N. A. N. A. Patented [1]
Dipeptide analog 1 DM2OTJS N. A. N. A. Patented [1]
Peptide analog 14 DMN97QF N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Proteasome beta-5 (PS beta-5)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Peptide analog 21 DMJDFS1 N. A. N. A. Patented [1]
Peptide analog 23 DMDU21R N. A. N. A. Patented [1]
PMID29865878-Compound-53 DM6JV1W N. A. N. A. Patented [1]
PMID29865878-Compound-55 DMY52ZB N. A. N. A. Patented [1]
PMID29865878-Compound-46 DMP3MXK N. A. N. A. Patented [1]
PMID29865878-Compound-48 DMVQTR2 N. A. N. A. Patented [1]
PMID29865878-Compound-51 DM0LXT2 N. A. N. A. Patented [1]
PMID29865878-Compound-49 DMK0GTV N. A. N. A. Patented [1]
Peptide analog 37 DMVX71N N. A. N. A. Patented [1]
Peptide analog 38 DM9FL81 N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Proteasome beta-1 (PS beta-1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Peptide analog 21 DMJDFS1 N. A. N. A. Patented [1]
Peptide analog 23 DMDU21R N. A. N. A. Patented [1]
PMID29865878-Compound-53 DM6JV1W N. A. N. A. Patented [1]
PMID29865878-Compound-55 DMY52ZB N. A. N. A. Patented [1]
PMID29865878-Compound-46 DMP3MXK N. A. N. A. Patented [1]
PMID29865878-Compound-48 DMVQTR2 N. A. N. A. Patented [1]
PMID29865878-Compound-51 DM0LXT2 N. A. N. A. Patented [1]
PMID29865878-Compound-49 DMK0GTV N. A. N. A. Patented [1]
Peptide analog 39 DMYJOTP N. A. N. A. Patented [1]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Targeting Proteasome beta-2 (PS beta-2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Peptide analog 21 DMJDFS1 N. A. N. A. Patented [1]
Peptide analog 23 DMDU21R N. A. N. A. Patented [1]
Peptide analog 37 DMVX71N N. A. N. A. Patented [1]
Peptide analog 38 DM9FL81 N. A. N. A. Patented [1]
Peptide analog 39 DMYJOTP N. A. N. A. Patented [1]
Peptide analog 36 DMB4LNI N. A. N. A. Patented [1]
⏷ Show the Full List of 6 Drug(s)
Drug(s) Targeting Proteasome beta-8 (PS beta-8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
M3258 DM6PI5B Multiple myeloma 2A83 Phase 1 [2]
Peptide analog 21 DMJDFS1 N. A. N. A. Patented [1]
Peptide analog 23 DMDU21R N. A. N. A. Patented [1]
PMID29865878-Compound-53 DM6JV1W N. A. N. A. Patented [1]
PMID29865878-Compound-55 DMY52ZB N. A. N. A. Patented [1]
PMID29865878-Compound-46 DMP3MXK N. A. N. A. Patented [1]
PMID29865878-Compound-48 DMVQTR2 N. A. N. A. Patented [1]
PMID29865878-Compound-51 DM0LXT2 N. A. N. A. Patented [1]
PMID29865878-Compound-49 DMK0GTV N. A. N. A. Patented [1]
Peptide analog 27 DML4XJ2 N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Proteasome beta-1 (PS beta-1) TT8EPLT PSB6_HUMAN Inhibitor [1]
Proteasome beta-2 (PS beta-2) TT49BVC PSB7_HUMAN Inhibitor [1]
Proteasome beta-5 (PS beta-5) TT68GPI PSB5_HUMAN Inhibitor [1]
Proteasome beta-8 (PS beta-8) TTEAD9J PSB8_HUMAN Inhibitor [1]
Proteasome beta-9 (PS beta-9) TTOUSTQ PSB9_HUMAN Inhibitor [1]

References

1 A patent review of immunoproteasome inhibitors.Expert Opin Ther Pat. 2018 Jul;28(7):517-540.
2 Clinical pipeline report, company report or official report of EMD Serono.